183 related articles for article (PubMed ID: 28494252)
1. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors.
Jia H; Song Y; Yu J; Zhan P; Rai D; Liang X; Ma C; Liu X
Eur J Med Chem; 2017 Aug; 136():144-153. PubMed ID: 28494252
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors.
Jia H; Bai F; Liu N; Liang X; Zhan P; Ma C; Jiang X; Liu X
Eur J Med Chem; 2016 Nov; 123():202-210. PubMed ID: 27484509
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors.
Qiu J; Gong Q; Gao J; Chen W; Zhang Y; Gu X; Tang D
Eur J Med Chem; 2018 Jan; 144():424-434. PubMed ID: 29288943
[TBL] [Abstract][Full Text] [Related]
4. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and antihepatitis B virus activities of novel 2-pyridone derivatives.
Lv Z; Sheng C; Wang T; Zhang Y; Liu J; Feng J; Sun H; Zhong H; Niu C; Li K
J Med Chem; 2010 Jan; 53(2):660-8. PubMed ID: 20000776
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of new N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents.
Lv Z; He W; Tian X; Kang J; Liu Y; Peng Y; Zheng L; Wang Q; Yu W; Chang J
Eur J Med Chem; 2015 Aug; 101():103-10. PubMed ID: 26119991
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors.
Geng CA; Huang XY; Ma YB; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2015 Apr; 25(7):1568-71. PubMed ID: 25737009
[TBL] [Abstract][Full Text] [Related]
9. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
Li Z; Min Q; Huang H; Liu R; Zhu Y; Zhu Q
Bioorg Med Chem Lett; 2018 May; 28(9):1501-1506. PubMed ID: 29627260
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of caudatin analogs as potent hepatitis B virus inhibitors.
Wang LJ; Chen H; Ma YB; Huang XY; Geng CA; Zhang XM; Chen JJ
Med Chem; 2015; 11(2):165-79. PubMed ID: 25181984
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M
Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and bioevaluation of paeonol derivatives as potential anti-HBV agents.
Huang TJ; Chuang H; Liang YC; Lin HH; Horng JC; Kuo YC; Chen CW; Tsai FY; Yen SC; Chou SC; Hsu MH
Eur J Med Chem; 2015 Jan; 90():428-35. PubMed ID: 25461891
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives.
Liu S; Li Y; Wei W; Wang K; Wang L; Wang J
Chem Biol Interact; 2016 May; 251():1-9. PubMed ID: 26980103
[TBL] [Abstract][Full Text] [Related]
15. 2-Arylthio-5-iodo pyrimidine derivatives as non-nucleoside HBV polymerase inhibitors.
Wang J; Zhang L; Zhao J; Zhang Y; Liu Q; Tian C; Zhang Z; Liu J; Wang X
Bioorg Med Chem; 2018 May; 26(8):1573-1578. PubMed ID: 29459146
[TBL] [Abstract][Full Text] [Related]
16. Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus.
Qu SJ; Wang GF; Duan WH; Yao SY; Zuo JP; Tan CH; Zhu DY
Bioorg Med Chem; 2011 May; 19(10):3120-7. PubMed ID: 21524588
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non-nucleoside hepatitis B virus inhibitors by exploring the solvent-exposed region.
Yu J; Jia H; Guo X; Desta S; Zhang S; Zhang J; Ding X; Liang X; Liu X; Zhan P
Chem Biol Drug Des; 2020 Jun; 95(6):567-583. PubMed ID: 30825248
[TBL] [Abstract][Full Text] [Related]
18. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation.
Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y
ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113
[TBL] [Abstract][Full Text] [Related]
19. Anti-hepatitis B virus and anti-cancer activities of novel isoflavone analogs.
Zhang Y; Zhong H; Lv Z; Zhang M; Zhang T; Li Q; Li K
Eur J Med Chem; 2013 Apr; 62():158-67. PubMed ID: 23353737
[TBL] [Abstract][Full Text] [Related]
20. Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors.
Qiu J; Chen W; Zhang Y; Zhou Q; Chen J; Yang L; Gao J; Gu X; Tang D
Eur J Med Chem; 2019 Aug; 176():41-49. PubMed ID: 31091479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
